Aims To determine whether n-3 polyunsaturated fatty acids (PUFAs) have cardiac antiarrhythmic effects and, if so, to determine the basis(es) for such an effect.
Introduction
For some fifty years there have been reports stating that free fatty acids, rapidly released from ischaemic myocardium, may play a role in initiating fatal ventricular arrhythmias which contribute to sudden cardiac death from acute myocardial infarctions. However, in 1975 there were suggestions by Gudbjarnason and Hallgrinsson [1] that fish oils might prevent fatal arrhythmias in humans. Murnaghan [2] reported in 1985 that while saturated fatty acids added to the perfusate of isolated rabbit hearts in vitro lowered the arrhythmia threshold, the addition of polyunsaturated alphalinolenic acid (C18:3n-3, LNA) raised the threshold. But the definitive studies were conducted by McLennan et al. [3] . McLennan also reported [4] that some 40% of rats, fed diets in which the major fatty acid component could be controlled, developed intractable ventricular fibrillation (VF) when their coronary arteries were ligated after some 3 months of the diet. This incidence of VF was unchanged with olive oil (monounsaturated), but was reduced by some 70% when the major source of dietary fat was from vegetable oils. With tuna fish oil, McLennan reported irreversible ventricular arrhythmias to be prevented with or without reflow to the ischaemic myocardium. These striking findings led us to pursue the possible mechanisms for such an antiarrhythmic action of the fish oil.
Studies on a canine model
Initially we wanted to see if we could confirm the findings of McLennan and Charnock. We studied a reliable canine model of sudden cardiac death with G. E. Billman, of The State University of Ohio, Columbus OH [5] . A surgically induced myocardial infarction was produced by ligating the left main coronary artery and an inflatable cuff was placed around the left circumflex artery. During the month of recovery the animals were taught to run on a treadmill. Table 1 summarizes our results. In 10 of the 13 prepared dogs, intravenous infusion of an emulsion of a concentrate of the fish oil free fatty acids (PUFAs) just prior to the exerciseischaemia test prevented the fatal VF (P<0·005) [6] .I n the control exercise-ischaemia tests 1 week prior to the test with the infusion of the PUFAs and 1 week following that test, all animals developed ischaemia-induced VF requiring prompt defibrillation. In additional studies, we have found that pure eicosapentaenoic acid (C20:5n-3, EPA) or docosahexaenoic acid (C22:6 n-3, DHA), or alpho-linolenic acid (C18:3n-3, LNA) delivered on serum albumin are antiarrhythmic in this dog preparation [7] with the same high probability, although the number of animals tested were too few to determine relative efficacy. We purposely infused the n-3 fatty acids rather than fed the dogs fish oil to be certain exactly what ingredient of the fish oil prevented the fatal VF. In dietary studies invariably several things will change, which may confound the study, but when the free fatty acids were infused intravenously just before producing the ischaemia and the fatal VF is prevented, then we think we can feel confident that the effect results from what had just been infused.
Mechanism of antiarrhythmic action of PUFAs in cultured neonatal rat cardiomyocytes
Having thus confirmed the findings of the earlier workers, although administering the PUFAs acutely and intravenously rather than by diet, we investigated the mechanism by which the n-3 polyunsaturated fatty acids (PUFA) produced their antiarrhythmic effect. To have a simple, available model to study in which we could visualize the production of arrhythmias and possible prevention of the arrhythmias by the PUFA, we studied cultured neonatal rat cardiac myocytes [8] . Hearts are quickly removed from 1-2-day-old decapitated rat pups. The cardiac cells are separated with trypsin and collaginase digestion and the cells are plated on microscope cover slips. By the second day of culture clumps of a few to several hundred myocyte cells grow adherent to the cover slips. Each group of cells is contracting spontaneously, synchronously and rhythmically. With a microscope, a video camera, and an edge monitor we can focus on a single myocyte in a clump of cells to see and record the rate and amplitude of contractions, as shown in Fig. 1 . With this in vitro model we produced arrhythmias with a number of chemicals known to produce fatal VF in humans: elevated extracellular [Ca 2+ ], toxic levels of the cardiac glycoside ouabain [8] , excessive -adrenergic agonist isoproterenol [9] , lysophosphatidyl choline, acyl or palmitoylcarnitine and even the calcium inophore A23187 [10] . With each agent a tachyarrhythmia was induced. If the PUFAs were added to the fluid perfusing the isolated myocytes before the arrhythmogenic toxins were administered, they would in every instance prevent the expected arrhythmia. If the arrhythmia was first induced by the toxin and the PUFAs added to the superfusate in the continued presence of the toxin, within a few minutes the arrhythmia would be terminated and the cells would resume beating regularly. Then, in the continued presence of the toxin, the PUFAs can be extracted from the cells with delipidated bovine serum albumin and the arrhythmia promptly resumes [8] . Figure 2 shows one such experiment which was particularly informative to us. The results indicated that it was only the free PUFAs partitioning into the membrane phospholipids that prevented the arrhythmias. If the fatty acid had been covalently bound to any constituent in the membrane, we would not have been able to extract it from the membrane. When the ethyl esters or the triglycerides of the PUFAs were tested, it was not antiarrhythmic in this model; the free carboxylic acid group is essential for this antiarrhythmic action. Figure 1 Shows simply a tracing of the rate and amplitude of contraction of a single cultured neonatal heart cell within a clump of cardiac myocytes adherent to a microscope cover slip in a perfusion chamber as recorded with an inverted microscope, a video camera and an edge monitor [8] . The cells were beating regularly when addition to the superfusate of low micromolar concentrations of (A) EPA or (B) DHA were added to the superfusate. This slowed the beating rate of the myocyte. However, this effect was reversible as shown by the return to the control beating rate when the free fatty acids were extracted from the cell by delipidated bovine serum albumin (2 mg . ml 1 ) added to the perfusate. The bottom tracing (C) shows that the antiarrhythmic local anaesthetic lidocaine, which is known to block Na + channels, had similar effects in this preparation.
We then tested which PUFAs were antiarrhythmic [8] . Both the n-3 and n-6 classes of PUFAs are antiarrhythmic, whereas monounsaturated oleic acid and the saturated fatty acids (stearic, palmitic and lauric) were not. However, arachidonic acid (C20n-6, AA) was anomalous. Cyclooxygenase metabolites of AA (except prostacyclin) cause arrhythmias, whereas cyclooxygenase metabolites of n-3 EPA do not [11] . This would account for the remaining fatal arrhythmias observed in the study by McLennan [4] when he fed his rats a vegetable oil, safflower oil, which is rich in n-6 polyunsaturated fatty acids. To avoid arrhythmias induced by prostaglandins of n-6 arachidonic acid, we have advised that only the n-3 PUFAs should be tested in clinical trials as antiarrhythmic agents.
The structural requirements for an antiarrhythmic compound that acts in the manner of these PUFAs are a long acyl or hydrocarbon chain with two or more C=C unsaturated bonds and a free carboxyl group at one end. With this guideline we found all-trans retinoic acid also to be specifically antiarrhythmic, whereas retinal and retinol were not [12] . The antiarrhythmic action of the PUFAs results from their effects on the electrophysiology of cardiac myocytes [13] . They cause slight hyperpolarization of the resting or diastolic membrane potential and the threshold voltage for the opening of the Na + channel becomes more positive. This results in an increased depolarizing stimulus of about 40-50% required to induce an action potential. In addition, the refractory period, phase 4 of the cardiac cycle, is prolonged some threefold. These two effects on every myocyte in the heart would account for the increased electrical stability and resistance of the heart to lethal arrhythmias.
This electrical stabilizing effect of the n-3 PUFAs on every cardiomyocyte can be readily demonstrated in vitro [10] . Figure 3 shows the tracing of the rate and amplitude of contractions of a single cardiomyocyte in a clump of cells growing on a microscope coverslip. When two platinum electrodes were placed across the microscope coverslip in a perfusion chamber and connected to an external voltage source, the regular beating rate could easily be doubled by stimulating the myocyte by the external field of 15 V. When the external voltage source was turned off the myocyte regained its prior beating rate. When the same cell was exposed to n-3 EPA (15 M) added to the superfusate, the beating rate began to slow down -a highly reproducible effect of the PUFAs on the neonatal rat cardiomyocytes -and now the myocyte paid no attention to the stimuli from the external voltage source at 15 or at 20 V. However, external stimuli delivered at 25 V succeeded in eliciting myocyte contractions, but only in response to every other electrical stimulus. When delipidated bovine serum albumin (2 mg . ml 1 ) was added to the superfusate of the same coverslip to extract the free fatty acid from the cardiomyocytes, the beating rate returned to its control 
The effects of n-3 PUFAs on the arrhythmic actions of [Ca 2+ ] e (5 or 7 mM) and the cardiac glycoside ouabain (0·1 mM) on cultured neonatal rat cardiomyocytes [8] . Both elevated Ca 2+ (A) and ouabain (B) caused contracture and fibrillation of the myocytes. But when the EPA was added prior to the calcium or ouabain it slowed the beating rate and prevented the fibrillation (C). When both ouabain and calcium were added to the superfusate they caused a violent arrhythmia, which was terminated by adding EPA to the same superfusate. The cells resumed a fairly regular rhythm, but when the free fatty acid was extracted from the myocytes by delipidated bovine serum albumin, still in the presence of the ouabain and elevated Ca 2+ , the violent arrhythmia promptly resumed. Figure 3 The effect of EPA on the response of the cultured neonatal rat cardiomyocytes to electrical stimuli delivered from an external applied electrical voltage source [10] . The three strips are continuous tracings of the contraction rate and amplitude of a single myocyte within a clump of myocytes. The spontaneous beating rate and amplitude of contraction is apparent in the top tracing. An external electric field of 15 V delivered stimuli at a rate that readily doubled the beating rate. The second tracing shows that with EPA (15 M) added to the superfusate the beating rate slowed, but when an external electrical field of 15 V was applied the cells paid no attention to the stimuli, nor did they at 20 V. At 25 V they responded but only to every other stimulus. Upon addition of delipidated bovine serum albumin to the superfusate the free EPA was extracted from the cardiomyocyte, the contractions returned to the control rate, and now the cells doubled their beating rate in response to stimuli delivered at 15 V, just as they had initially.
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Eur Heart J Supplements, Vol. 3 (Suppl D) June 2001 frequency and now the myocytes responded to the external electrical stimuli delivered at 15 V, as they had initially. When one considers that this electrical stabilization is an effect of the PUFAs directly on every cardiac myocyte, both atrial and ventricular, in the absence of neural or humoral effects, one can sense what a potent antiarrhythmic action these n-3 PUFAs may exert. Furthermore, the antiarrhythmic action should be independent of the pathological condition causing the arrhythmias.
Effects of PUFAs on membrane ion currents
These effects in turn result from an action of the PUFAs to modulate the conductance of ion channels in the plasma membranes of the heart cells. The voltage-gated sodium current, I Na , initiates and propagates action potentials in most cardiac myocytes. Our finding that the PUFAs increased the magnitude of a depolarizing stimulus required to elicit an action potential made it likely that the PUFAs were affecting the I Na . Thus our exploration of the effects of the PUFAs on membrane ion currents and channels began with I Na .
Effects on sodium channels
The PUFAs inhibited the I Na in a concentrationdependent manner, with an IC 50 of 4·8 M in neonatal rat cardiomyocytes [14] but only 0·51 0·06 Mi na human embryonic kidney cell line, HEK293t, transiently expressing human myocardial sodium -subunits, hH1 [15] (Fig. 4) . Inhibition occurred within seconds of application of the PUFAs to the myocytes. It was voltage-dependent, but not use-dependent, and consistent with the lipophilic nature of the PUFAs [16] . In both preparations -I Na in the rat cardiomyocyte and I Na in the human myocardial -subunit transiently expressed in HEK293t cells -the PUFAs caused a large voltagedependent shift of the steady state inactivation potential to more hyperpolarized values; the shift at V 1/2 = 19 mV with 10 M EPA in the neonatal rat cardiomyocyte and a further 27·8 mV with 5 M EPA in the hH1 . There was no effect of the PUFAs on the activation of the Na + channels, only on the inactivated channel (Fig. 5) . The PUFAs prolonged the inactivated state of the hH1 channels by speeding the transition from the active to the inactivated state and retarding the slow inactivation phase of the channel. In more recent studies [17] the 1 subunit has been transiently coexpressed with the -subunit in HEK293t cells and this shifted the steady state inactivation potential to the right (to more depolarized potentials) returning the electrophysiology of the hH1 channels almost to exactly that observed for the neonatal rat cardiomyocytes. EPA was found to have no effect on the activation but only on the inactivation of I Na, ,I Na and I Na,rat . Consistent with the effects of these fatty acids solely on the inactivated state of the Na + channel, is the finding that the binding or interaction of these fatty acids to the inactivated state of the Na + channels displayed a 265-fold higher affinity for 5 M EPA than channels in the closed resting, but activatable, state of hH1 .
These effects of the n-3 PUFAs (and DHA and LNA do the same as EPA) we think are pertinent to the antiarrhythmic actions of these fatty acids. Our current hypothesis is that this voltage-dependent shift of the steady state inactivation potential to more negative, hyperpolarizing voltages is important to the observed antiarrhythmic action of the PUFAs in ischaemiainduced fatal arrhythmias. With a coronary thrombosis a gradient of depolarizations of cardiomyocytes occurs within the ischaemic tissue. Cells in the central core of the ischaemic tissue quickly depolarize and die due to lack of oxygen and metabolic substrates. Depolarization results from the dysfunctional state of Na, K-ATPase and the rise of interstitial K + concentrations in the ischaemic tissue. At the periphery of the ischaemic zone myocytes may be only partially depolarized. They become hyperexcitable since their resting membrane potentials become more positive, approaching the threshold for the gating of the fast Na + channel. Thus, any further small depolarizing stimulus (e.g. currents of injury) may elicit an action potential, which, if it occurs out of phase with the electrical cycle of the heart, may initiate an arrhythmia. In the presence of the n-3 
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Eur Heart J Supplements, Vol. 3 (Suppl D) June 2001 PUFAs, however, a voltage-dependent shift of the steady-state inactivation potential to more hyperpolarized resting potentials occurs. The consequence of this voltage-dependent, hyperpolarizing shift is that the negative potential necessary to return these Na + channels from an inactive state to a closed resting, but activatable state, requires a physiologically unobtainable hyperpolarized resting membrane potential. These partially depolarized cells also have Na + channels which, within milliseconds, can slip into 'resting inactivation' from the closed resting state without eliciting an action potential [15] . The result of these two effects of the n-3 PUFAs is that these partially depolarized myocytes are quickly eliminated from function, and their potential arrhythmic mischief is aborted. By contrast, myocytes in the non-ischaemic myocardium, with normal resting membrane potential, will not be so drastically affected by this voltage-dependent action of the PUFAs and continue to function normally [17] .
Effects on calcium channels
Disturbed regulation of cytosolic free calcium concentrations is another cause of malignant arrhythmias occurring in ischaemia or resulting from a variety of cardiac toxins. Elevations of cytosolic calcium concentrations can result in increased frequency and amplitude of contraction of myocytes leading to tachyarrhythmias and delayed after-potentials.
The effects of the n-3 PUFAs on arrhythmias induced by some cardiac toxins shown in Fig. 2 [8] are examples of arrhythmias induced by excessive cytosolic Ca 2+ fluctuations. Figure 6 is another example in which the cytosolic free Ca 2+ fluctuations were recorded simultaneously with the contractile activity of the neonatal cardiomyocytes [10] . In this experiment lysophophatidylcholine (LPC), an amphiphile, was the toxic agent. It has been incriminated as one of the endogenous chemical mediators of ventricular arrhythmias in ischaemic myocardium, which accumulates very early in the ischaemic heart. In Fig. 6A [10] are shown the simultaneous tracings of myocyte contraction (top) and cytosolic free Ca 2+ levels, as estimated by 360/380 nm fluorescence intensity ratio of Fura 2 (lower tracing) in a spontaneously contracting control myocyte before and after the addition of EPA (10 M) to the superfusate. The contraction of the myocyte results from the spike in cytosolic free Ca 2+ which precedes the contraction spike by some 50 ms. The time-averaged cytosolic free Ca 2+ levels remain very low, normally about 100 nM. EPA reduced the beating rate without altering the amplitude of contractions, as reported [8] . On another myocyte, which had a slow endogenous beating rate, Fig. 6B shows the effect of LPC (5 M) on increasing the cytosolic free Ca Such excessive cytosolic-free Ca 2+ fluctuations as shown in Fig. 6B after LPC can induce delayed afterpotentials, which may trigger fatal arrhythmias if the after-potential occurs at a vulnerable moment in the electrical cycle of the heart. Because both I Ca,L and sarcoplasmic reticulum Ca 2+ -release underlie many [15] . (A) Averaged and normalized current-voltage relationships (n=6) of I Na are plotted, showing the inhibition of the peak Na + current in the presence of EPA and partial recovery following washout of EPA. (B) The averaged relative activation of I Na (right) was unaffected by EPA and the three curves -control, EPA and washout -of normalized activation were superimposable. By contrast (left), EPA produced an impressive shift of the steady state inactivation to more hyperpolarized potentials and this was largely reversible on washout of the EPA. The same unchanged activation curves were also found for the complete hH1 sodium channel with both alpha and beta-1 units co-expressed [17] , and for the neonatal rat cardiac myocyte [14] . The shift of the steady state inactivation potential to more negative potentials also occurred with hH1 and for the rat myocyte. The shifts were similar for both but not as large as seen in hH1 .
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Eur Heart J Supplements, Vol. 3 (Suppl D) June 2001 cardiac arrhythmias, we examined the effects of the PUFAs on I Ca,L and Ca 2+ sparks, together with A. M. Gomez and W. J. Lederer [18] . Whole-cell voltage clamp techniques and confocal Ca 2+ imaging were used to determine the effects of PUFAs on the voltage-gated L-type Ca 2+ current (I Ca,L ), elementary sarcoplasmic reticulum Ca 2+ -release events (Ca 2+ -sparks), and [Ca 2+ ] i transients in isolated adult rat ventricular myocytes. Extracellular application of eicosapentaenoic acid and the other antiarrhythmic polyunsaturated fatty acids, but not saturated or monounsaturated fatty acids, produced a prompt and reversible concentrationdependent inhibition of I Ca,L . The concentration of EPA to produce 50% inhibition of I Ca,L was 0·8 Mi n neonatal rat heart cells and 2·1 M in adult rat ventricular myocytes. Although the EPA-induced suppression of I Ca,L , did not significantly alter the shape of the currentvoltage relationship, it produced a small, but significant, negative shift of the steady-state inactivation curve ( V 1/2 = 3to 5mV). The suppression of the I Ca,L by the PUFAs was voltage-and time-dependent but not use-dependent. The effects of the PUFAs on I Ca,L resemble their effects on I Na , except that the steady state inactivation potentials for I Ca,L were shifted to the left to a much lesser degree.
When heart cells become 'overloaded' with Ca 2+ , they become arrhythmogenic and produce arrhythmogenic I TI currents and waves of elevated [Ca 2+ ] i that propagate within the heart cell. During the Ca 2+ overload the ryanodine receptors (RyRs) become more sensitive to the triggering process, produce an increased number of spontaneous Ca 2+ sparks, and produce propagating waves of elevated Ca 2+ , all of which can be viewed with the confocal microscope while measuring membrane current. Thus it seems our finding that the n-3 PUFAs are potent inhibitors of I Ca,L and that this prevents the cytosolic Ca 2+ overload [18] appears to be the major mechanism by which this cause of triggered arrhythmias evoked by ischaemia or cardiac toxins are prevented by the PUFAs.
Effect on other sarcolemmal ion currents
Although at present we think that inhibitory effects of the PUFAs on I Na and I CaL seem the major effects accounting for their antiarrhythmic actions, we are not unmindful that they affect other sarcolemmal ion currents as well. By whole-cell voltage-clamp measurements we and others (Y-F. Xiao. unpublished results) have found that the PUFAs also inhibit K + currents -the transient outward current, I to , and the delayed rectifier current, I K , but not the inward rectifying current, I K1 . However, these influences on the important repolarizing K + currents would have the effect of prolonging the action potential duration, whereas the PUFAs, if anything, slightly shorten the action potential duration [13] . Also the concentrations of EPA required to affect the repolarizing K + currents were considerably larger than those required to affect the I Na and the I Ca,L ,a sd escribed above. However, Xiao has found other cardiac transmembrane ion currents are also affected by the PUFAs. All ion currents that he has examined in cardiac myocytes have been found to be inhibited by the same PUFAs (Y-F. Xiao, unpublished data) including the cardiac chloride current and the ligand-activated acetylcholine potassium current.
Toxicity questions
When we found that the n-3 PUFAs inhibited the voltage-dependent sodium current, I Na , as potently as do the class I sodium channel-blocking drugs, we were concerned that the antiarrhythmic fatty acids might prove to be as toxic clinically as the class I drugs. The reason for the toxicity of the sodium channel-blocking drugs does not yet seem to be understood. Duff and Catterall suggested one interesting possibility from their experiments [19, 20] . They found that administration of mexiletine, a class I antiarrhythmic drug to rats resulted in an up-regulation of cardiac Na + channel expression, as shown by increase in both the level of mRNA encoding Na + channel alpha-subunits and the number of sodium channels per cell. It was suggested that the increased number of sodium channels caused by chronic treatment by these drugs may secondarily itself cause 
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Eur Heart J Supplements, Vol. 3 (Suppl D) June 2001 arrhythmias. Whether or not their proposal is correct, J. Kang tested the effects of EPA, mexiletine, and the two agents together on cultured neonatal rat cardiac myocytes. He found, as had Duff and Catterall, a two-to fivefold increase in the number of Na + per cell and similar increase in mRNA encoding the Na + channel protein in the myocytes cultured with mexiletine, but no increase over control levels in the myocytes cultured in the presence of n-3 EPA [21] . Combining the two agents reduced the Na + channels and mRNA per cell by about one-third. Chronic treatment with potent calcium channel-blocking drugs probably results in similar up-regulation of L-type Ca 2+ channels per cell, since cardiac myocytes are competent nucleated cells. When agents block an important cellular function, the affected cell can respond by making more of the elements that are responsible for that function. That the n-3 PUFAs can produce blockage of channels while obviating the cells, response to generate more channels, suggests some quite fundamental difference in the actions of the two ion channel-blocking agents on the myocytes. Perhaps over the millennia that these fatty acids have been part of the human diet [22] , Nature has adapted important physiological functions for them in ways that were safe for humans.
Once we found that these fatty acids modulated the ion channels in the heart excitable tissue, we strongly suspected they would similarly affect other excitable tissues, namely muscles and the nervous system as they all utilize highly homologous electrical communicating systems -and they do. Vreugdenhil et al. [23] determined the effect of these n-3 fatty acids on the sodium and calcium channels of the hippocampal CA1 neurons of rats and found they were both modulated very similarly to their effects in the heart cells. A functional consequence of this action on the sodium and calcium channels was tested with Voskuyl [24] , who found the polyunsaturated free fatty acids to have anticonvulsant effects in rats, using the cortical stimulation model to induce seizures. There has not been time to pursue the nervous system effects of these antiarrhythmic fatty acids further, but the effects we have found, I think, support our findings in the heart and hopefully will be pursued by others.
An aspect of human nutrition
Finally, for those of you who may share the scepticism I have had about the veracity of this presentation -until I saw the data unfold -let me try to put this into the larger picture of human nutrition. This was an attempt with Weber to utilize the methods of evolutionary medicine to find the place of n-3 PUFAs in human nutrition [22] . Admittedly the method in this case is very crude, but our best estimates suggest that these fatty acids were once present in human diet in amounts nearly as large as were the other, or n-6 class, of polyunsaturated fatty acids. This was during the 2-4 million years of human existence during which our genes were adapted to our environment, including our diets (Fig. 7) . Deviation began some 10-15 thousand years ago (too short a time to affect genetic adaptation significantly) with adoption of agriculture and animal husbandry mainly of ruminants. The agriculture introduced grains and n-6-rich vegetable oils into the diet and the ruminants, partially hydrogenated polyunsaturated fatty acids depriving the PUFAs of their special benefits. The situation was aggravated further by the Industrial Revolution with further hydrogenation of PUFAs for margarine and increased consumption of animal fat. n-3 Fatty acids have been declining in our diets while the n-6 vegetable oils have increased. No one is surprised today that the n-6 fatty acids have been adapted by Nature to provide, via the arachidonic acid cascade, a host of potent cell messengers: prostaglandins, leukotrienes, lipoxins and epoxygenase products. But if one suggests that during this same period the n-3 class of PUFAs may also have been adapted for important functions, some of which may antagonize the effects of excesses of arachidonic acid in our bodies, disbelief is the common response. I think that we are just at the modest beginnings of comprehending what these safe and interesting PUFAs may do for human health.
Conclusions
It is apparent that there exists a basic control of cardiac and other excitable tissues by common dietary fatty acids which has been largely overlooked. With some 250 000 sudden cardiac deaths annually, largely due to ventricular fibrillation, in the U.S.A. alone and millions more worldwide, there may be a potential large public health benefit from the practical application of this recent understanding. Initial reports suggest that the n-3 PUFAs are producing beneficial effects in the treatment of depression [25] , bipolar and other behavioural diseases [26] . The knowledge that these fatty acids have direct physical effects on the fundamental property of the nervous system, namely its electrical activity, should encourage further exploration of potential beneficial effects on brain functions both normal and pathological. It seems likely that we are just scratching the surface of the potential health effects of these interesting dietary polyunsaturated fatty acids.
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